You are here » Home » Companies » Company Overview » Natco Pharma Ltd

Natco Pharma Ltd.

BSE: 524816 Sector: Health care
NSE: NATCOPHARM ISIN Code: INE987B01026
BSE LIVE 15:46 | 02 Dec 588.05 -12.70
(-2.11%)
OPEN

598.00

HIGH

601.00

LOW

583.00

NSE LIVE 15:55 | 02 Dec 588.25 -13.05
(-2.17%)
OPEN

598.95

HIGH

601.00

LOW

583.10

OPEN 598.00
PREVIOUS CLOSE 600.75
VOLUME 16399
52-Week high 703.95
52-Week low 390.00
P/E 48.44
Mkt Cap.(Rs cr) 10249.71
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 598.00
CLOSE 600.75
VOLUME 16399
52-Week high 703.95
52-Week low 390.00
P/E 48.44
Mkt Cap.(Rs cr) 10249.71
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Natco Pharma Ltd.

Natco Pharma Ltd

Incorporated in Sep.'81 as Natco Fine Pharmaceutical Ltd, it became a deemed public company with effect from Jul.'92 and in Feb.'93, it changed its name to Natco Pharma (NPL). NPL began to manufacture conventional and time-release dosage forms of life-saving drugs. NPL is a contract manufacturer for reputed companies like Ranbaxy and Parke Davis. It has also obtained the coveted ISO 9002 certifica...> More

Natco Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   10,250
EPS - TTM () [*C] 12.14
P/E Ratio (X) [*C] 48.44
Face Value ()   2
Latest Dividend (%)   37.50
Latest Dividend Date 19 Aug 2016
Dividend Yield (%) 0.21
Book Value / Share () [*C] 80.37
P/B Ratio () [*C] 7.32
[*C] Consolidated     [*S] Standalone

Natco Pharma Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 467.86 243.02 92.52
Other Income 3.18 2.07 53.62
Total Income 471.04 245.09 92.19
Total Expenses 363.05 184.81 96.44
Operating Profit 107.99 60.28 79.15
Net Profit 66.22 28.9 129.13
Equity Capital 34.83 34.83 -
> More on Natco Pharma Ltd Financials Results

Natco Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Syngene Intl. 574.40 -5.10 11488.00
Jubilant Life 691.40 -2.49 11014.00
Abbott India 4838.70 -0.15 10282.24
Natco Pharma 588.05 -2.11 10249.71
Sanofi India 4254.20 -1.20 9797.42
Strides Shasun 1075.60 -0.08 9612.64
Pfizer 1882.20 -0.18 8611.06
> More on Natco Pharma Ltd Peer Group

Natco Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 51.28
Banks/FIs 0.10
FIIs 19.37
Insurance 0.00
Mutual Funds 6.41
Indian Public 19.17
Custodians 0.00
Other 3.66
> More on Natco Pharma Ltd Share Holding Pattern

Natco Pharma Ltd - Research Reports

Date Broker Action Price Report
26/05 Reliance Securities Buy 2336 PDF IconDetails
> More on Natco Pharma Ltd Research Reports

Natco Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -1.57% -1.76% -0.33% -0.34%
1 Month 0.17% 0.27% -4.71% -5.02%
3 Month -13.53% -13.13% -8.07% -8.21%
6 Month 23.14% 23.39% -2.28% -1.61%
1 Year 13.78% 14.13% 0.43% 1.96%
3 Year 274.27% 273.44% 25.52% 30.06%

Natco Pharma Ltd - STOCK STRENGTH

Today's Low/High 583.00
601.00
Week Low/High 545.00
626.00
Month Low/High 495.00
685.00
YEAR Low/High 390.00
704.00
All TIME Low/High 1.60
704.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard